mRNA production and analysis.
Our new BASE Clinical laboratories are opening in 2024 at the Translational Research Institute (TRI).
BASE Clinical will provide the process development, production and analysis services needed to progress mRNA vaccines and therapies to clinical outcomes.
BASE Clinical produces mRNA and LNP for Phase-1 clinical trials undertaken in Australia.
We are also closely integrated within the Queensland clinical trials network.
BASE Clinical can provide comprehensive quality control testing of mRNA and LNPs.
Our expert quality control team has established assays to measure mRNA and LNP attributes (including identity, integrity, capping efficiency, impurities, size, dispersion and safety).
Research Laboratories
Level 3, AIBN (#75)
The University of Queensland
St Lucia, QLD 4072
Manufacture Facility
Level 6, Translational Research Institute
37 Kent St
Woolloongabba, QLD 4102